Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2010
08/04/2010CN1918141B Aminodibenzodioxin derivative and organic electroluminescent device using same
08/04/2010CN101796054A 1,4-diaza-bicycl0(3.2.2)n0nyl pyrimidinyl derivatives useful as nicotinic acetylcholine- receptor ligands
08/04/2010CN101796053A Piperidine derivatives useful as orexin receptor antagonists
08/04/2010CN101796052A Pyrrolopyridine derivatives and their use as BACE inhibitors
08/04/2010CN101796051A substituted heterocycle fused gamma-carbolines synthesis
08/04/2010CN101792443A Fluoro-carbostyril derivative as well as preparation method and application thereof
08/04/2010CN101792442A Production method based on harmel alkaloid physical and chemical properties
08/04/2010CN101792422A Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/03/2010US7767824 5,5-dibenzylimidazo[2,1-b]thiazol-6(5H)-one, useful as cognition activators in connection with treatments on memory disturbance, memory acquirement and retention disturbance, for example in Alzheimer's disease
08/03/2010US7767816 for treating proliferative disorders, cardiac disorders, neurodegenerative disorders, autoimmune disorders, conditions associated with organ transplantation, inflammatory disorders, and/or immunologically mediated disorders
08/03/2010US7767810 Macrocyclic modules comprising linked cyclic synthon units for use in the formation of selectively permeable membranes
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767701 protein serine/threonine kinase inhibitors such as 2-(2-Chloro-5-fluoro-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one, used for treating autoimmune diseases, HIV, cancer, anemia myelodysplastic syndrome and thrombocytopenia
08/03/2010US7767687 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors
08/03/2010US7767676 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy
08/03/2010US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators
08/03/2010US7767193 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
08/03/2010CA2591818C Process for the preparation of optically active aminoalcohols
08/03/2010CA2441792C Carboline derivatives as inhibitors of phosphodiesterase 5 (pdes) for the treatment of cardiovascular diseases and erectile dysfunction
07/2010
07/29/2010WO2010085684A1 Compositions and methods for inhibition of the jak pathway
07/29/2010WO2010085597A1 Macrocyclic compounds and their use as kinase inhibitors
07/29/2010WO2010085570A1 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
07/29/2010WO2010084852A1 Light-emitting element material and light-emitting element
07/29/2010WO2010084425A1 New adenosine receptor ligands and uses thereof
07/29/2010WO2010084185A1 Novel indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use
07/29/2010WO2010084184A1 N-oxides of diazabicyclononyl pyrimidine derivatives and their medical use
07/29/2010WO2010084121A1 Novel diaza-bicyclononyl-pyrimidinyl derivatives and their medical use
07/29/2010WO2010084120A1 N-oxides of 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine receptor ligands
07/29/2010WO2010084097A1 Spiroindolinone derivative prodrugs
07/29/2010WO2010014930A3 Piperidine derivatives as jak3 inhibitors
07/29/2010WO2009156724A3 Pyrido-indole-carboxylic acid compounds
07/29/2010WO2009143347A9 Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
07/29/2010WO2009068482A8 Amino triazoles as pi3k inhibitors
07/29/2010US20100190985 Heterodiamondoids
07/29/2010US20100190820 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
07/29/2010US20100190819 alpha-7 Nicotinic Acetylcholine Receptor Allosteric Modulators, Their Derivatives and Uses Thereof
07/29/2010US20100190814 Spiroindolinone derivative prodrugs
07/29/2010US20100190801 Triazolopyridine derivatives as inhibitors of lipases and phospholipases
07/29/2010US20100190788 Amide derivatives as kinase inhitors
07/29/2010US20100190780 Sigma receptor inhibitors
07/29/2010US20100190777 Compounds and methods for kinase modulation, and indications therefor
07/29/2010US20100190773 Anti-Cytokine Heterocyclic Compounds
07/29/2010US20100190766 Antibacterial agents
07/29/2010US20100190763 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
07/29/2010US20100190753 Methods and Compositions for Treating Amyloid-Related Diseases
07/29/2010US20100190746 Quinazolinones as potassium channel modulators
07/29/2010US20100189708 Hydroxy piperidine derivatives to treat gaucher disease
07/29/2010US20100189648 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
07/29/2010US20100187978 Material for organic electro-optical device having fluorene derivative compound and organic electro-optical device including the same
07/29/2010US20100187520 Light emitting device material and light emitting device
07/29/2010US20100187519 Material for organic electroluminescent element, and organic electroluminescent element
07/29/2010US20100187505 Benzanthracene derivatives for organic electroluminescent devices
07/29/2010CA2750450A1 Novel indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use
07/29/2010CA2750449A1 New adenosine receptor ligands and uses thereof
07/29/2010CA2750447A1 N-oxides of diazabicyclononyl pyrimidine derivatives and their medical use
07/29/2010CA2750106A1 Poly (adp-ribose) polymerase (parp) inhibitors
07/29/2010CA2749217A1 Compositions and methods for inhibition of the jak pathway
07/29/2010CA2748957A1 Spiroindolinone derivative prodrugs
07/28/2010EP2210892A2 Neurologically-active compounds
07/28/2010EP2210891A1 New adenosine receptor ligands and uses thereof
07/28/2010EP2209784A1 Compounds for the treatment of hepatitis c
07/28/2010EP2209783A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
07/28/2010EP2209782A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
07/28/2010EP2209780A2 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf- kappa b activity and use thereof
07/28/2010EP2209775A1 Heterobicyclic compounds as histamine h4-receptor antagonists
07/28/2010EP2079721B1 Process for the preparation of (s)-4-fluoromethyl-dihydro-furan-2-one
07/28/2010EP1979349B1 Anti-viral compounds
07/28/2010EP1551844B1 Antitumoral analogs of lamellarins
07/28/2010EP1458392B9 Acridones as inhibitors of impdh enzyme
07/28/2010CN1788000B Phthalazinone derivatives
07/28/2010CN101790532A Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
07/28/2010CN101790531A Process for the preparation of pyrido [2, 1-a] isoquinoline derivatives and polymorphic froms thereof
07/28/2010CN101790530A Bis-carbazole DNA intercalating agents for antitumor therapy
07/28/2010CN101787025A Substituted-evodiamine anti-tumor and antifungal compounds and preparation method thereof
07/28/2010CN101787024A Quinoline
07/28/2010CN101787023A Dimer salt of quinoline alkaloid, preparation method and application thereof
07/28/2010CN101787022A Quinoline carboxylic acid hydrochloride-hydrate novel crystal form, preparation method and application thereof
07/27/2010US7763747 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis
07/27/2010US7763731 effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses; (7-Methyl-[1,8]naphthyridin-4-yl)-(5-methyl-2-phenylsulfanyl-phenyl)-amine
07/27/2010US7763728 Tetrahydropyridothiophenes
07/27/2010US7763725 Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists and antagonists of melanocortin receptors
07/27/2010US7763636 N-(arylalkyl)-1H-pyrrolopyridine-2-carboxamide derivatives, preparation and therapeutic use thereof
07/27/2010US7763634 Inhibitors of janus kinases
07/27/2010US7763633 such as 6-[2-(4-Hydroxyphenyl)ethylamino]-11H-indolo[3,2-c]quinoline, used to inhibit both growth of cancer cells and activity of telomerase
07/27/2010US7763622 such as 5-methyl-6-(2-chloro-4-fluorophenyl)-7-(4-methylpiperidin-1-yl)-[1,2,4]-triazolo[1,5-a]pyrimidine, used for controlling phytopathogenic fungi; improved fungicidal activity
07/27/2010US7763621 3-[[6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-2,5-dimethyl-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine, used for the treatment of osteoporosis, restenosis, arteriosclerosis, nephropathy or retinopathy
07/27/2010US7763616 Chemokine receptor antagonists, used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, hypersensitivity responses, ophthalmic inflammation, diabetes, viral meningitis and tumors
07/27/2010CA2445625C Pyrazino'1',2':1,6!pyrido'3,4-b!indole1,4-dione derivatives
07/22/2010WO2010083444A1 Alpha7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
07/22/2010WO2010083264A1 Novel benzenesulfonamides as calcium channel blockers
07/22/2010WO2010083141A1 Bicyclic compounds for the reduction of beta-amyloid production
07/22/2010WO2010083136A1 Oxadiazole beta carboline derivatives as antidiabetic compounds
07/22/2010WO2010082563A1 Cyclic compound having hetero atom
07/22/2010WO2010082111A1 Preparation of 3-(2-hydroxy ethyl)-9-hydroxy-2-methyl-4h-pyrido-[1,2-a]-pyrimidin-4-one or its acid addition salt
07/22/2010WO2010082044A1 Unsaturated bicyclic heterocyclic derivatives as smo antagonists
07/22/2010WO2010081874A1 Naphthyridin-2 (1 h)-one compounds useful as antibacterials
07/22/2010WO2010081859A1 6-phenyl-lh-imidazo [4, 5-c] pyridine-4-carbonitrile derivatives as cathepsin s and/or cathepsin k inhibitors
07/22/2010WO2010081266A1 A new use of tetrahydropalmatine
07/22/2010WO2010015586A3 2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds
07/22/2010WO2010007046A3 Heteroaryl derivatives as dgat1 inhibitors
1 ... 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 ... 646